The tweet was deleted by the author.
But we saved everything 🙂.
Quest Diagnostics achieved a milestone with the approval of Haystack MRD by New York State.
With this approval, Haystack MRD is now available in all 50 U.S. states. Quest Diagnostics said this will help expand access to advanced cancer monitoring.
DGX is trading firmly above its MA-20 ($197.63), MA-50 ($194.89), and MA-200 ($189.74), highlighting a persistent bullish structure across all primary timeframes. The Ichimoku Kijun on D1 stands at $196.98, placing it below the current price and establishing this level as immediate support.
Momentum on D1 is strong, as MACD signals a strong buy while ADX remains subdued at 13.96, pointing to a trend but with limited conviction. RSI is neutral-to-bullish at 50.52, and Stoch RSI gives a strong buy signal, although BBP indicates slight seller dominance with oversold classification. CCI and the Awesome Oscillator remain neutral and add little directional bias. In today's session, the stock rallied 3.01%, pointing to renewed buyers’ interest. Over the last week, DGX has advanced $8.11 (4.16%) from a previous weekly close of $195.00. The price now sits at the very top of this week's range, with weekly volatility standing at 2.55%. This marks a decisive recovery from last week's lows and a test of upper resistance.
For the coming week, the expected price range is $203.00 to $208.50, tightly anchored near the current price and well within the recent yearly high of $213.50 and above the 52-week low of $164.65. Based on W1 signals (RSI, ADX, MACD, MA-50), there is a very high probability (more than 80%) of further upside, with a downtrend scenario much less likely. Baseline scenario: DGX consolidates between immediate support ($197.00–$198.00) and resistance ($205.80–$208.50). Bullish scenario: a breakout above near-term resistance opens the path towards retesting yearly highs. Bearish scenario: sustained weakness below $197 would challenge key support at $194.90.
Earlier, analysts noted that Quest Diagnostics was experiencing short- and medium-term bearish pressure while consolidating above longer-term support levels. Building on this, current market conditions highlight the need for traders to monitor potential upside momentum should DGX stabilize above its recent support zone.